[Neurofibromatosis type 2]

Area of Science:

• Genetics
• Neurology
• Oncology

Context:

• Type 2 neurofibromatosis (NF2) is a rare, inherited, autosomal dominant disorder.
• It is often misdiagnosed as Type 1 neurofibromatosis.
• NF2 is characterized by schwannomas, meningiomas, and other central nervous system tumors.

Purpose:

• To differentiate NF2 from NF1.
• To highlight the genetic basis of NF2.
• To discuss the clinical presentation and management of NF2.

Summary:

• Inheriting a mutated NF2 gene leads to tumor development, typically before age 30.
• Mosaicism accounts for approximately 20% of sporadic NF2 cases.
• Surgical treatment morbidity is significant; however, advancements like cochlear implants improve outcomes.

Impact:

• Early identification of NF2 mutations is possible in most families.
• Prognostic factors include age at diagnosis, intracranial meningiomas, and treatment at a specialty center.
• Understanding NF2 is crucial for accurate diagnosis and effective patient management.